0.00
0.00
(0.00%)
This company is not ACTIVE.
Axcan Pharmaceuticals
AXP-T
Analysis and Opinions about AXP-T
Signal
Opinion
Expert
TOP PICK
TOP PICK
April 14, 2005
Part pharmaceutical and part drug development. Very profitable. Strong balance sheet and lots of cash flow. Generates about US$1.50 free cash flow every year. In a very stable gastro-intestinal market. They're also in-licence some drugs which gives them some pretty good upside. Trading at about US$14 with $1 a share free cash on the balance sheet.
Show full opinionHide full opinion
Part pharmaceutical and part drug development. Very profitable. Strong balance sheet and lots of cash flow. Generates about US$1.50 free cash flow every year. In a very stable gastro-intestinal market. They're also in-licence some drugs which gives them some pretty good upside. Trading at about US$14 with $1 a share free cash on the balance sheet.
TOP PICK
TOP PICK
November 24, 2004
A very focused (gastro intestinal) pharmaceutical company and as a result, it is very profitable. You pretty well get a free call option on a potentially block-buster drug called Itax. Huge market in North America.
Show full opinionHide full opinionA very focused (gastro intestinal) pharmaceutical company and as a result, it is very profitable. You pretty well get a free call option on a potentially block-buster drug called Itax. Huge market in North America.
TOP PICK
TOP PICK
November 9, 2004
Last news was that R&D spending would be higher than the street anticipated. Launching a product that could be a $200 million product.
Show full opinionHide full opinionLast news was that R&D spending would be higher than the street anticipated. Launching a product that could be a $200 million product.
BUY
BUY
November 11, 2003
Has a very good ROE. Efficient balance sheet structure. Continuing to grow their earnings. Valuation is reasonable.
Show full opinionHide full opinionHas a very good ROE. Efficient balance sheet structure. Continuing to grow their earnings. Valuation is reasonable.
TOP PICK
TOP PICK
November 3, 2003
The entire US financial sector is attractive. Their brokerage sector is growing rapidly. Expects travel business will pick up.
Show full opinionHide full opinionThe entire US financial sector is attractive. Their brokerage sector is growing rapidly. Expects travel business will pick up.
DON'T BUY
DON'T BUY
May 20, 2003
Its OK earnings wise. They are trying to make a hostile take over which looks expensive. Core business is OK.
Show full opinionHide full opinionIts OK earnings wise. They are trying to make a hostile take over which looks expensive. Core business is OK.
BUY
BUY
January 20, 2003
A good long term hold. They focus on their earnings. Well managed.
Show full opinionHide full opinionA good long term hold. They focus on their earnings. Well managed.
DON'T BUY
DON'T BUY
Had a nice run. May be a bit high now.
STRONG BUY
STRONG BUY
December 11, 2000
Products selling very well. Sales force based in US
Show full opinionHide full opinionProducts selling very well. Sales force based in US
Showing 1 to 9
of 9 entries
- «
- ‹
- 1
- ›
- »
Axcan Pharmaceuticals(AXP-T) Rating
Ranking : 1 out of 5
Bullish - Buy Signals / Votes : 0
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 0
Total Signals / Votes : 0
Axcan Pharmaceuticals(AXP-T) Frequently Asked Questions
What is Axcan Pharmaceuticals stock symbol?
Axcan Pharmaceuticals is a OTC stock, trading under the symbol AXP-T on the (). It is usually referred to as or AXP-T
Is Axcan Pharmaceuticals a buy or a sell?
In the last year, there was no coverage of Axcan Pharmaceuticals published on Stockchase.
Is Axcan Pharmaceuticals a good investment or a top pick?
Axcan Pharmaceuticals was recommended as a Top Pick by Chris Fernyc on 2005-04-14. Read the latest stock experts ratings for Axcan Pharmaceuticals.
Why is Axcan Pharmaceuticals stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Axcan Pharmaceuticals worth watching?
In the last year 0 stock analysts on Stockchase covered Axcan Pharmaceuticals. The stock is worth watching.
What is Axcan Pharmaceuticals stock price?
On , Axcan Pharmaceuticals (AXP-T) stock closed at a price of $.
